Traditional Chinese medicine composition for preventing and treating senile dementia and hemiplegia sequelae

A technology for senile dementia and sequelae, applied in drug combinations, pharmaceutical formulations, plant raw materials, etc., can solve the problems of unsatisfactory cost for severe patients, unsatisfactory long-term efficacy, and aggravation of illness, and achieve the improvement of normal pressure hypoxia tolerance, The effect of promoting meningeal microcirculation and improving physical activity

Inactive Publication Date: 2019-12-03
马合奎
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At the end of the 20th century, the advent of cerebrolysin set up a milestone in the treatment of senile dementia, and it is also the first choice of western medicine. Termination of treatment makes the condition worse and worse, and the long-term curative effect is mostly unsatisfactory

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0311] A honeyed pill for preventing and treating senile dementia and sequelae of hemiplegia, comprising:

[0312] Take 9g of ginseng, 3g of Cordyceps sinensis, 10g of turtle shell, 4g of leech, 1.5g of horsefly, 10g of cassia twig, 30g of white peony, 30g of Bupleurum, 10g of aurantium, 30g of kudzu root, 6g of roasted licorice, 6g of ephedra, 3g of saffron, peach kernel 6g, Danpi 6g, Fushen 15g, Panax notoginseng 5g, Yizhiren 30g, cornus 10g, Eucommia 15g, wine rhubarb 2g, polygala 10g, nuxychonzi 0.3g and dried ginger 5g, grind them into powder, pass Sieve 160 meshes, add honey 250g to the fine powder, and make honeyed pills by the conventional process of honeyed pills, which is the marrow Haidan, and every pill weighs 3.5 grams.

[0313] Observation on clinical curative effect of treating senile dementia with Chinese medicine composition of the present invention

[0314] 1. General information

[0315] 300 patients, including 180 males and 120 females, aged 30-88 years, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a traditional Chinese medicine composition for preventing and treating senile dementia and hemiplegia sequelae and belongs to the field of traditional Chinese medicine pharmacy. The traditional Chinese medicine composition for preventing and treating the senile dementia and the hemiplegia sequelae is prepared from the following raw materials: 3-9g of ginseng, 3-6g of cordyceps, 10-20g of processed carapax trionycis, 2-5g of hirudo, 1.5-3g of gadfly, 10-30g of cassia twig, 10-30g of radix paeoniae alba, 12-45g of radix bupleuri, 10-20g of fructus aurantii immaturus, 15-45g of radix puerariae, 6-9g of prepared licorice root, 6-20g of herba ephedrae, 3-10g of saffron, 6-15g of semen persicae, 6-15g of cortex moutan, 12-30g of poria with hostwood, 5-10g of radix notoginseng, 20-45g of fructus alpiniae oxyphyllae, 10-25g of fructus corni, 10-25g of cortex eucommiae, 2-6g of rhubarb stir-fried with wine, 10-15g of radix polygalae, 0.3-0.6g of semen strychni, 3-10g ofrhizoma zingiberis and 200-300g of honey. The traditional Chinese medicine composition provided by the invention can effectively solve the problems of the senile dementia and the hemiplegia sequelaeas well as is safe and reliable in clinical medication and low in cost.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for preventing and treating senile dementia and sequelae of hemiplegia, belonging to the field of traditional Chinese medicine pharmacy. Background technique [0002] At present, senile dementia is one of the three major diseases that cause senile disability. In my country, the rate of senile dementia among the elderly over 65 years old is about 5%-7%, and there are more hemiplegia patients. It seriously endangers the life and health of the elderly. . At the end of the 20th century, the advent of cerebrolysin set up a milestone in the treatment of senile dementia, and it is also the first choice of western medicine. If the treatment is terminated, the condition will worsen day by day, and the long-term curative effect is mostly unsatisfactory. Contents of the invention [0003] In order to solve the above technical problems, the present invention provides a traditional Chinese medic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61P9/00A61P25/00A61P25/28A61K35/586A61K35/62A61K35/64A61K35/644
CPCA61K35/586A61K35/62A61K35/64A61K35/644A61K36/068A61K36/076A61K36/17A61K36/233A61K36/258A61K36/40A61K36/46A61K36/484A61K36/488A61K36/54A61K36/56A61K36/65A61K36/69A61K36/708A61K36/71A61K36/736A61K36/752A61K36/88A61K36/9062A61K36/9068A61P9/00A61P25/00A61P25/28A61K2300/00
Inventor 马合奎马月月
Owner 马合奎
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap